日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The potential of lazertinib and amivantamab combination therapy as a treatment strategy for uncommon EGFR-mutated NSCLC

拉泽替尼和阿米凡他单抗联合疗法作为治疗罕见EGFR突变型非小细胞肺癌的潜在策略

期刊:Cell Reports Medicine
影响因子:11.7
doi:10.1016/j.xcrm.2025.101929
Seung Yeon Oh ，Sewon Park ，Seoyoung Lee ，Eun Ji Lee ，Tae Ho Kim ，Su-Jin Choi ，So Young Park ，Jae Hwan Kim ，Sun Min Lim ，Jii Bum Lee ，Byoung Chul Cho ，Min Hee Hong ，Mi Ran Yun
肿瘤免疫
EGFR
细胞生物学
肺癌
EGF
肿瘤
发表日期：2025
文献求助 收藏

DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapy

DNA 甲基化组和单细胞转录组分析表明 CDA 是 ALK 抑制剂耐药肺癌治疗的潜在药物靶点

期刊:Experimental and Molecular Medicine
影响因子:9.5
doi:10.1038/s12276-022-00836-7
Haejeong Heo #, Jong-Hwan Kim #, Hyun Jung Lim, Jeong-Hwan Kim, Miso Kim, Jaemoon Koh, Joo-Young Im, Bo-Kyung Kim, Misun Won, Ji-Hwan Park, Yang-Ji Shin, Mi Ran Yun, Byoung Chul Cho, Yong Sung Kim, Seon-Young Kim #, Mirang Kim #
信号转导
肿瘤
表观遗传
肺癌
其它细胞
WB
DNA甲基化
发表日期：2022
文献求助 收藏

Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models

患者和患者来源的临床前模型中奥希替尼耐药性的分子图谱

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.3
doi:10.1177/17588359221079125.
Sun Min Lim ,San-Duk Yang ,Sangbin Lim ,Seong Gu Heo ,Stetson Daniel ,Aleksandra Markovets ,Rafati Minoo ,Kyoung-Ho Pyo ,Mi Ran Yun ,Min Hee Hong ,Hye Ryun Kim ,Byoung Chul Cho
发表日期：2022
文献求助 收藏

Incorporation of SKI-G-801, a Novel AXL Inhibitor, With Anti-PD-1 Plus Chemotherapy Improves Anti-Tumor Activity and Survival by Enhancing T Cell Immunity

新型 AXL 抑制剂 SKI-G-801 与抗 PD-1 加化疗相结合，通过增强 T 细胞免疫力提高抗肿瘤活性和存活率

期刊:Frontiers in Oncology
影响因子:3.5
doi:10.3389/fonc.2022.821391
Wongeun Lee, Dong Kwon Kim, Chun-Bong Synn, Hee Kyu Lee, Sungho Park, Dong-Sik Jung, Yewon Choi, Jae Hwan Kim, Youngseon Byeon, Young Seob Kim, Seul Lee, Soyeon Lee, Yunjoo Joo, Eun Ji Lee, Mi Ran Yun, Seong Gu Heo, Wookyeom Yang, Ji Eun Jung, Eun Kyung Kim, Jooyeon Park, June Dong Park, Doo Jae Lee
免疫
肿瘤
T细胞
发表日期：2022
文献求助 收藏

Primary Tumor Suppression and Systemic Immune Activation of Macrophages through the Sting Pathway in Metastatic Skin Tumor

转移性皮肤肿瘤中通过Sting通路抑制原发肿瘤和激活巨噬细胞的全身免疫反应

期刊:Yonsei Medical Journal
影响因子:2.6
doi:10.3349/ymj.2022.63.1.42
Chun-Bong Synn # ，Dong Kwon Kim # ，Jae Hwan Kim ，Youngseon Byeon ，Young Seob Kim ，Mi Ran Yun ，Ji Min Lee ，Wongeun Lee ，Eun Ji Lee ，Seul Lee ，You-Won Lee ，Doo Jae Lee ，Hyun-Woo Kim ，Chang Gon Kim ，Min Hee Hong ，June Dong Park ，Sun Min Lim ，Kyoung-Ho Pyo
免疫/内分泌
信号转导
肿瘤免疫
巨噬细胞
细胞生物学
肿瘤
巨噬细胞
发表日期：2022
文献求助 收藏

Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma

利用患者来源的晚期肺腺癌类器官模拟靶向治疗的临床反应

期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-20-5026
Seok-Young Kim #, Sang-Min Kim #, Sumin Lim, Ji Yeon Lee, Su-Jin Choi, San-Duk Yang, Mi Ran Yun, Chang Gon Kim, Seo Rin Gu, Chaewon Park, A-Young Park, Sun Min Lim, Seong Gu Heo, HyunKi Kim, Byoung Chul Cho
肿瘤
肺癌
Donkey
IgG
发表日期：2021
文献求助 收藏

SKI-G-801, an AXL kinase inhibitor, blocks metastasis through inducing anti-tumor immune responses and potentiates anti-PD-1 therapy in mouse cancer models

SKI-G-801 是一种 AXL 激酶抑制剂，它通过诱导抗肿瘤免疫反应来阻断转移，并在小鼠癌症模型中增强抗 PD-1 疗法的疗效。

期刊:Clinical & Translational Immunology
影响因子:4.6
doi:10.1002/cti2.1364
Chun-Bong Synn ，Sung Eun Kim ，Hee Kyu Lee ，Min-Hwan Kim ，Jae Hwan Kim ，Ji Min Lee ，Ha Ni Jo ，Wongeun Lee ，Dong Kwon Kim ，Youngseon Byeon ，Young Seob Kim ，Mi Ran Yun ，Chae-Won Park ，Jiyeon Yun ，Sangbin Lim ，Seong Gu Heo ，San-Duk Yang ，Eun Ji Lee ，Seul Lee ，Hunmi Choi ，You Won Lee ，Jae Seok Cho ，Do Hee Kim ，Sungho Park ，Jung-Ho Kim ，Yewon Choi ，Sung Sook Lee ，Beung-Chul Ahn ，Chang Gon Kim ，Sun Min Lim ，Min Hee Hong ，Hye Ryun Kim ，Kyoung-Ho Pyo ，Byoung Chul Cho
信号转导
肿瘤
免疫/内分泌
肿瘤免疫
AXL
PD-1
发表日期：2021
文献求助 收藏

Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion-Driven NSCLC

EGFR-MET 双特异性抗体 Amivantamab (JNJ-61186372) 在 EGFR 外显子 20 插入驱动的 NSCLC 的多种模型中的抗肿瘤活性

期刊:Cancer Discovery
影响因子:29.7
doi:10.1158/2159-8290.CD-20-0116
Jiyeon Yun, Soo-Hwan Lee, Seok-Young Kim, Seo-Yoon Jeong, Jae-Hwan Kim, Kyoung-Ho Pyo, Chae-Won Park, Seong Gu Heo, Mi Ran Yun, Sangbin Lim, Sun Min Lim, Min Hee Hong, Hye Ryun Kim, Meena Thayu, Joshua C Curtin, Roland E Knoblauch, Matthew V Lorenzi, Amy Roshak, Byoung Chul Cho
肿瘤
发表日期：2020
文献求助 收藏

Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck

小鼠-人类联合临床试验表明，布帕利西布（BKM120）与西妥昔单抗联合治疗头颈部鳞状细胞癌具有优异的抗肿瘤作用

期刊:British Journal of Cancer
影响因子:6.4
doi:10.1038/s41416-020-01074-2
Hye Ryun Kim #, Han Na Kang #, Mi Ran Yun, Kwon Young Ju, Jae Woo Choi, Dong Min Jung, Kyoung Ho Pyo, Min Hee Hong, Myoung-Ju Ahn, Jong-Mu Sun, Han Sang Kim, Jinna Kim, Jinseon Yoo, Kyu Ryung Kim, Yoon Woo Koh, Se Heon Kim, Eun Chang Choi, Sun Ock Yoon, Hyo Sup Shim, Soonmyung Paik, Tae-Min Kim, Byo
肿瘤
头颈癌
其它细胞
WB
Mouse
发表日期：2020
文献求助 收藏

Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer

建立并鉴定患者来源的异种移植作为头颈癌的临床模型

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-020-06786-5
Han Na Kang, Jae-Hwan Kim, A-Young Park, Jae Woo Choi, Sun Min Lim, Jinna Kim, Eun Joo Shin, Min Hee Hong, Kyoung-Ho Pyo, Mi Ran Yun, Dong Hwi Kim, Hanna Lee, Sun Och Yoon, Da Hee Kim, Young Min Park, Hyung Kwon Byeon, Inkyung Jung, Soonmyung Paik, Yoon Woo Koh, Byoung Chul Cho, Hye Ryun Kim
肿瘤
头颈癌
发表日期：2020
文献求助 收藏